Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Kidney Medicine
|
December 3, 2025
Comparison of Thiazide Versus Alkali for Kidney Stone Recurrence Among Individuals With Hypocitraturia and High Urine pH
Ryan S Hsi, Mary K Oerline, Sara L Best, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 3, 2024
Real-World Effectiveness of Preventive Pharmacological Therapy in Patients With Urolithiasis: A Retrospective Cohort Study
John M Hollingsworth, Mary K Oerline, Ryan S Hsi, et al.
Urology Practice
|
April 27, 2023
Potential for Urolithiasis-related Research Using the Novel Medicare-Litholink Database
Noah A Krampe, Mary K Oerline, John R Asplin, et al.
Urology
|
July 22, 2021
Complementary and Alternative Medicine Use in First-time and Recurrent Kidney Stone Formers
Aditya Joshi, Jacob E Tallman, Joshua K Calvert, et al.
The Journal of Urology
|
October 7, 2014
Provider variation in the quality of metabolic stone management
Casey A Dauw, Abdulrahman F Alruwaily, Maggie J Bierlein, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 17, 2012
Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers
David E Leaf, Ruslan Korets, Eric N Taylor, et al.
Kidney International
|
February 19, 2002
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats
David A Bushinsky, John R Asplin, Marc D Grynpas, et al.
Urology
|
July 27, 2015
Geographic Variation in the Quality of Secondary Prevention for Nephrolithiasis
Abdulrahman F Alruwaily, Casey A Dauw, Maggie J Bierlein, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria
Nancy S Krieger, John R Asplin, Kevin K Frick, et al.
Kidney International
|
June 7, 2013
NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy
Felix Knauf, John R Asplin, Ignacio Granja, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Kidney Medicine
|
December 3, 2025
Comparison of Thiazide Versus Alkali for Kidney Stone Recurrence Among Individuals With Hypocitraturia and High Urine pH
Ryan S Hsi, Mary K Oerline, Sara L Best, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 3, 2024
Real-World Effectiveness of Preventive Pharmacological Therapy in Patients With Urolithiasis: A Retrospective Cohort Study
John M Hollingsworth, Mary K Oerline, Ryan S Hsi, et al.
Urology Practice
|
April 27, 2023
Potential for Urolithiasis-related Research Using the Novel Medicare-Litholink Database
Noah A Krampe, Mary K Oerline, John R Asplin, et al.
Urology
|
July 22, 2021
Complementary and Alternative Medicine Use in First-time and Recurrent Kidney Stone Formers
Aditya Joshi, Jacob E Tallman, Joshua K Calvert, et al.
The Journal of Urology
|
October 7, 2014
Provider variation in the quality of metabolic stone management
Casey A Dauw, Abdulrahman F Alruwaily, Maggie J Bierlein, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 17, 2012
Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers
David E Leaf, Ruslan Korets, Eric N Taylor, et al.
Kidney International
|
February 19, 2002
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats
David A Bushinsky, John R Asplin, Marc D Grynpas, et al.
Urology
|
July 27, 2015
Geographic Variation in the Quality of Secondary Prevention for Nephrolithiasis
Abdulrahman F Alruwaily, Casey A Dauw, Maggie J Bierlein, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria
Nancy S Krieger, John R Asplin, Kevin K Frick, et al.
Kidney International
|
June 7, 2013
NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy
Felix Knauf, John R Asplin, Ignacio Granja, et al.
Page
of 10